4. Ideal Option for Women Aiming for Weight Loss
Current Drug Targets CNS and Neurological Disorders 4, 267-281CrossRefGoogle ScholarPubMed 118Calkins, M.J., Johnson, D.A., Townsend, J.A
Known as semaglutide and marketed under names such as Ozempic and WeGovy, the drug has recently gained popularity as a weight-loss tool
But for others, it may lead to: Loss of food enjoyment Disconnection from hunger and fullness cues Increased rigidity around eating behaviors Unintentional restriction with long-term mental and physical consequences For endurance athletes, eating is not just a preferenceits part of the job
The key consideration for seasonal residents is continuity
It is easy to use with simple maintenance procedure